灵活的实证贝叶斯式药监方法,用于自发报告数据系统中的同时信号检测和信号强度估计
Yihao Tan1, Marianthi Markatou1, Saptarshi Chakraborty1
1Department of Biostatistics, School of Public Health and Health Professions, State University of New York at Buffalo, Buffalo, New York, USA.
本研究引入了新的,可扩展的贝叶斯制药监测方法,以改善自发报告系统数据库中不良事件信号的检测和强度估计,以降低计算成本.
科学领域:
- 药物监督和贝叶斯统计数据
- 计算毒理学和药物安全
- 在医疗保健中的数据科学.
背景情况:
- 自发报告系统 (SRS) 对于识别医疗产品的不良事件至关重要.
- 现有的AE信号检测贝叶斯方法由于限制性假设和高计算需求而面临局限性.
- 需要有效和灵活的方法来准确评估AE信号强度.
研究的目的:
- 开发新的,可扩展的实证贝叶斯方法用于药监.
- 加强从SRS数据库中检测和估计AE信号.
- 以较低的计算成本为AE信号强度提供准确的不确定性量化.
主要方法:
- 在实证贝叶斯建模中使用了灵活的非参数先验.
- 开发定制,高效的数据驱动估计技术,用于信号检测和强度估计.
- 采用了广泛的模拟实验,并将方法应用于FDA FAERS对他类药物的数据.
主要成果:
- 提出的方法实现了与现有的贝叶斯方法相比或比现有的贝叶斯方法更好的信号检测性能.
- 在信号强度估计方面表现出卓越的准确性,通过复制根平均平方误差来测量.
- 通过使用频率主义虚假发现率和灵敏度指标保持或超过最先进的信号检测性能.
结论:
- 新的经验贝叶斯方法为药监提供了一个可扩展和计算效率高的药监解决方案.
- 这些方法为AE信号强度提供了高准确度估计和不确定性量化,增强了对AE相关性的洞察力.
- 应用到现实世界的数据 (FDA FAERS) 产生了关于他类药物相关不良事件的重大发现.
更多相关视频
12:30Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
Published on: March 5, 2012
07:28Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity
Published on: January 21, 2017
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Statistical Methods for Analyzing Epidemiological Data
